VocaMedi
HomeMedical DictionaryReye syndrome
📢Advertisement[top]
ICD-10: G93.7acute metabolic encephalopathyNEUROLOGICALMETABOLICRARE DISEASES

Reye syndrome

ray syndrome

Also known as: Reye's syndrome, Fatty liver with encephalopathy

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

At a Glance

Type
acute metabolic encephalopathy
Age of Onset
primarily affects children and teenagers
Inheritance
not inherited
Prevalence
1 in 1,000,000

What is Reye syndrome?

Reye syndrome is a rare but serious condition that causes swelling in the liver and brain. It primarily affects children and teenagers recovering from a viral infection, such as the flu or chickenpox. The exact cause is unknown, but it has been linked to aspirin use in children with viral illnesses. Early symptoms include vomiting and confusion, which can quickly progress to seizures and loss of consciousness. Early diagnosis and treatment are crucial to prevent severe complications or death. The syndrome can be life-threatening and often requires intensive medical care. Families may experience significant stress and disruption due to the sudden and severe nature of the illness. The prognosis varies; some individuals recover fully, while others may suffer from long-term neurological damage. Daily life for affected individuals and their families can be challenging, especially if there are lasting effects. The condition is preventable by avoiding aspirin in children with viral infections. Public health campaigns have significantly reduced its incidence by educating about the risks of aspirin use in children. Despite its rarity, awareness remains important to prevent new cases.

Medical Definition

Reye syndrome is an acute, non-inflammatory encephalopathy with fatty degeneration of the liver and other viscera. Pathologically, it is characterized by microvesicular steatosis in the liver and cerebral edema. Histological findings include swollen hepatocytes with fat vacuoles and minimal inflammation. It is classified under acute metabolic encephalopathies and is most prevalent in children aged 4 to 12 years. The disease course can be rapid, progressing from mild symptoms to severe neurological impairment within hours. Epidemiologically, its incidence has declined significantly due to increased awareness of the association with aspirin use in pediatric viral infections.

Reye syndrome Symptoms

Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.

Very Common

Vomiting

Vomiting in Reye syndrome often presents suddenly and can be severe. It is caused by increased intracranial pressure and liver dysfunction leading to metabolic imbalances. Over time, persistent vomiting can lead to dehydration and electrolyte disturbances. This affects daily life by causing discomfort and weakness, and management includes rehydration and monitoring of electrolytes.

Confusion

Confusion manifests as disorientation and difficulty in thinking clearly. It results from encephalopathy due to liver dysfunction and accumulation of toxic substances in the brain. As the condition progresses, confusion can worsen, leading to more severe neurological symptoms. This impacts daily life by impairing cognitive functions, and management involves supportive care and monitoring of neurological status.

Lethargy

Lethargy is characterized by extreme tiredness and lack of energy. It is caused by metabolic disturbances and central nervous system involvement. Over time, lethargy can progress to stupor or coma if not addressed. It affects daily life by limiting physical activity and responsiveness, and management includes addressing the underlying metabolic issues.

Common

Seizures

Seizures in Reye syndrome can occur as a result of increased intracranial pressure and metabolic imbalances. The biological mechanism involves abnormal electrical activity in the brain due to encephalopathy. Seizures can vary in frequency and severity, potentially leading to further neurological damage. They impact daily life by posing a risk of injury and require anticonvulsant therapy and close monitoring.

Irritability

Irritability is often seen as increased agitation and mood swings. It is caused by neurological disturbances and discomfort from the illness. As the syndrome progresses, irritability can escalate, contributing to stress for both the patient and caregivers. Management involves creating a calm environment and addressing the underlying neurological issues.

Hepatomegaly

Hepatomegaly is the enlargement of the liver, which can be detected through physical examination. It results from fatty infiltration and inflammation of the liver. Over time, hepatomegaly can lead to liver dysfunction and further metabolic complications. This affects daily life by causing abdominal discomfort and requires monitoring of liver function and supportive care.

Less Common

Jaundice

Jaundice presents as yellowing of the skin and eyes due to elevated bilirubin levels. It is caused by liver dysfunction and impaired bilirubin metabolism. Jaundice may develop as the disease progresses, indicating worsening liver function. This affects daily life by causing skin changes and requires monitoring and management of liver health.

Hyperventilation

Hyperventilation is characterized by rapid and deep breathing. It occurs as a compensatory mechanism for metabolic acidosis and increased intracranial pressure. Over time, hyperventilation can lead to respiratory alkalosis and further metabolic disturbances. Management involves addressing the underlying causes and ensuring adequate respiratory support.

What Causes Reye syndrome?

Reye syndrome is not directly linked to a specific gene mutation but is associated with mitochondrial dysfunction. The normal function of mitochondria is to produce energy in the form of ATP through oxidative phosphorylation. In Reye syndrome, mitochondrial enzymes are disrupted, impairing energy production. This disruption leads to an accumulation of toxic metabolites like ammonia and fatty acids. Organelle dysfunction results in impaired liver function and encephalopathy. Neighboring cells and tissues are affected by the buildup of these toxic substances, leading to widespread cellular damage. Neuroinflammation is triggered as the immune system responds to cellular stress and damage. This inflammation contributes to cerebral edema and increased intracranial pressure. White matter degeneration occurs due to the toxic effects of accumulated substances and inflammation. Symptoms appear in a pattern reflecting the organs most affected: the liver and brain. The severity of symptoms varies due to differences in mitochondrial enzyme activity and individual metabolic responses. Some patients may have mild symptoms, while others experience severe neurological damage. The exact cause of this variability is not fully understood but may involve genetic and environmental factors. Early diagnosis and treatment can mitigate some of the severe effects. Aspirin use in children with viral infections has been linked to the onset of Reye syndrome. Avoiding aspirin in these situations is a key preventive measure.

📢Advertisement[mid-content]

How is Reye syndrome Diagnosed?

Typical age of diagnosis: Reye syndrome is typically diagnosed in children and teenagers, often following a viral infection such as influenza or chickenpox. Diagnosis usually occurs when symptoms like persistent vomiting, confusion, and lethargy prompt medical evaluation. Early diagnosis is crucial to prevent progression to more severe neurological symptoms. The condition is rare, and awareness among clinicians aids in timely recognition.

1
Clinical Evaluation

Clinicians look for a history of recent viral illness and aspirin use, as these are common antecedents. Key history elements include the onset of vomiting, lethargy, and behavioral changes. Physical examination may reveal hepatomegaly and signs of increased intracranial pressure. This step helps direct the clinician towards considering Reye syndrome as a differential diagnosis.

2
Imaging Studies

A CT scan of the brain is typically used to assess for cerebral edema. Specific abnormalities such as diffuse brain swelling can be visible, supporting the diagnosis of Reye syndrome. Imaging findings help confirm the diagnosis by ruling out other causes of encephalopathy, such as intracranial hemorrhage. Differentials like meningitis or encephalitis are also considered and excluded based on imaging results.

3
Laboratory Tests

Blood tests are ordered to check liver function, ammonia levels, and coagulation profiles. Elevated liver enzymes, hyperammonemia, and prolonged prothrombin time are indicative of Reye syndrome. Abnormal results guide further management, including the need for intensive care. These tests help differentiate Reye syndrome from other metabolic disorders and liver diseases.

4
Genetic Testing

Genetic testing may involve sequencing genes related to fatty acid oxidation disorders. Mutations in genes such as CPT1A or ACADM can be found, which may mimic Reye syndrome. Although genetic testing is not routinely used for diagnosis, it can confirm the condition in atypical cases. Results provide information for family counseling regarding recurrence risks and genetic implications.

Reye syndrome Treatment Options

⚠️ All treatment decisions should be made in consultation with a specialist experienced in this condition.
PharmacologicalIntravenous Fluids and Electrolytes

Intravenous fluids are used to maintain hydration and electrolyte balance. The mechanism involves restoring normal blood volume and preventing dehydration. Specific fluids like dextrose solutions are used to manage hypoglycemia. Clinical evidence supports their efficacy in stabilizing patients and preventing complications. Limitations include the risk of fluid overload and electrolyte imbalances.

Physical TherapyRehabilitative Therapy

Techniques include range-of-motion exercises and strength training. Therapeutic goals focus on improving motor skills and preventing contractures. Sessions are typically conducted several times a week for a few months. Measurable outcomes include improved mobility and muscle strength. Long-term benefits include enhanced quality of life and independence.

SurgicalIntracranial Pressure Monitoring

Surgery is indicated for monitoring and managing increased intracranial pressure. The procedure involves placing a catheter in the brain to measure pressure levels. Expected benefits include prevention of brain damage due to swelling. Surgical risks include infection and bleeding at the insertion site. Post-operative care requires intensive monitoring in a hospital setting.

Supportive CareMultidisciplinary Care Model

The care team includes neurologists, pediatricians, and nutritionists. Specific interventions focus on nutritional support and managing complications. Psychosocial support strategies involve counseling and support groups for families. Family education covers disease management and recognizing early symptoms. A long-term monitoring plan includes regular follow-ups to assess recovery and prevent recurrence.

When to See a Doctor for Reye syndrome

🔴 Seek Emergency Care Immediately
  • Persistent vomiting — this can lead to severe dehydration and electrolyte imbalance, requiring immediate medical attention.
  • Rapid breathing or difficulty breathing — may indicate severe metabolic disturbances or brain swelling, necessitating emergency care.
  • Seizures — these are a sign of neurological involvement and can quickly become life-threatening without prompt treatment.
🟡 Contact Your Doctor Soon
  • Lethargy or unusual drowsiness — could indicate early brain involvement; seek medical evaluation.
  • Confusion or irritability — may suggest worsening neurological status; consult a healthcare provider.
  • Persistent headache — can be a sign of increased intracranial pressure; medical advice is recommended.
🟢 Monitor at Home
  • Mild nausea — monitor fluid intake and watch for worsening symptoms.
  • Fatigue — ensure adequate rest and hydration, and observe for any changes in behavior or alertness.

Reye syndrome — Frequently Asked Questions

Is this condition hereditary?

Reye syndrome is not considered hereditary and does not follow a clear inheritance pattern. The probability of passing it to children is low, as it is not linked to specific genetic mutations. De novo mutations are not typically associated with Reye syndrome. Carrier status does not apply to this condition. Genetic counseling is not generally recommended for Reye syndrome.

What is the life expectancy for someone with this condition?

Life expectancy varies significantly depending on the age of onset and severity of the condition. Early diagnosis and treatment improve outcomes, while delayed intervention can worsen prognosis. Mortality is primarily caused by complications such as brain swelling and liver failure. Prompt medical treatment can significantly enhance survival rates. Realistic expectations include the possibility of full recovery, especially with early intervention.

How is this condition diagnosed and how long does diagnosis take?

Diagnosis involves clinical evaluation, laboratory tests, and sometimes imaging studies. The time from first symptoms to diagnosis can vary, often taking days to weeks. Pediatricians and neurologists are typically consulted. Delayed diagnosis can occur due to the rarity of the condition and symptom overlap with other illnesses. Confirmation is usually achieved through a combination of clinical findings and laboratory results.

Are there any new treatments or clinical trials available?

Current research is focused on improving supportive care and understanding the pathophysiology of Reye syndrome. Gene therapy is not applicable, but novel approaches in metabolic management are being explored. Clinical trials can be found on ClinicalTrials.gov by searching for Reye syndrome. Patients should ask their doctors about eligibility for trials and emerging therapies. New treatments may take several years to become widely available.

How does this condition affect daily life and activities?

Reye syndrome can temporarily impact mobility and self-care, especially during acute phases. Educational implications may arise if neurological deficits persist. Social and emotional challenges include coping with illness and potential developmental delays. Family burden can be significant due to the need for intensive care and monitoring. Supportive therapies and educational adaptations are crucial for improving quality of life.

Support & Resources

National Reye's Syndrome Foundation
The National Reye's Syndrome Foundation provides information and support for families affected by Reye syndrome. They offer educational resources, advocacy, and a network for connecting with others. Contact them through their website for support and information.
Rare Diseases Clinical Research Network
This network facilitates research and collaboration on rare diseases, including Reye syndrome. It offers resources for finding clinical trials and connecting with research centers. Visit their website to learn more about ongoing studies and support opportunities.

References

Content generated with support from peer-reviewed literature via PubMed.

  1. 1.
    Reye's syndrome.

    Devivo DC, Keating JP · Adv Pediatr · 1976 · PMID: 817580

  2. 2.
    Reye syndrome.

    Kamienski MC · Am J Nurs · 2003 · PMID: 12865641

  3. 3.
    Reye's syndrome.

    Miller J, Arsenault L · J Neurosurg Nurs · 1983 · PMID: 6345731

  4. 4.
    Reye's syndrome.

    Rockoff MA, Pascucci RC · Emerg Med Clin North Am · 1983 · PMID: 6440775

  5. 5.
    [The Reye syndrome].

    Tanret I, Duh D · J Pharm Belg · 2011 · PMID: 21473127

  6. 6.
    Reye's syndrome.

    Schubert WK, Bobo RC, Partin JC et al. · Dis Mon · 1975 · PMID: 1104294

  7. 7.
    Reye's syndrome.

    Crocker JF · Semin Liver Dis · 1982 · PMID: 6763346

  8. 8.
    Reye's syndrome.

    Schiff GM · Annu Rev Med · 1976 · PMID: 779608

This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-04-30